IRIS UniCatt

Trecarichi, Enrico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.982
NA - Nord America 4.129
AS - Asia 3.582
SA - Sud America 578
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 13.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.013
DE - Germania 2.592
SG - Singapore 1.424
CN - Cina 1.329
SE - Svezia 545
BR - Brasile 447
IT - Italia 375
FR - Francia 341
UA - Ucraina 296
GB - Regno Unito 288
VN - Vietnam 240
IE - Irlanda 137
IN - India 112
TR - Turchia 94
FI - Finlandia 92
ID - Indonesia 88
PL - Polonia 83
RU - Federazione Russa 72
CA - Canada 54
AR - Argentina 53
BD - Bangladesh 52
HK - Hong Kong 42
JP - Giappone 40
MX - Messico 38
IQ - Iraq 30
NL - Olanda 28
BE - Belgio 25
EC - Ecuador 20
CO - Colombia 18
ES - Italia 15
VE - Venezuela 14
ZA - Sudafrica 14
PK - Pakistan 12
RO - Romania 12
SA - Arabia Saudita 12
AT - Austria 11
IR - Iran 11
IL - Israele 9
KR - Corea 9
AZ - Azerbaigian 8
CH - Svizzera 8
CI - Costa d'Avorio 8
JM - Giamaica 8
PH - Filippine 8
AU - Australia 7
JO - Giordania 7
KZ - Kazakistan 7
LT - Lituania 7
MA - Marocco 7
NP - Nepal 7
PE - Perù 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CL - Cile 5
HU - Ungheria 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
VA - Santa Sede (Città del Vaticano) 5
AL - Albania 4
ET - Etiopia 4
LV - Lettonia 4
PY - Paraguay 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BN - Brunei Darussalam 3
HR - Croazia 3
KG - Kirghizistan 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BY - Bielorussia 1
Totale 13.345
Salva come PNG Salva come JPEG
Città #
Singapore 787
Chandler 552
Hangzhou 441
Ashburn 420
San Jose 382
Jacksonville 205
Nürnberg 202
Beijing 199
San Mateo 153
Ann Arbor 144
Dublin 136
Nanjing 136
Dearborn 118
New York 103
Los Angeles 97
Jakarta 81
Wilmington 81
Izmir 75
Lauterbourg 74
Ho Chi Minh City 72
Milan 68
Hanoi 65
Munich 64
Woodbridge 63
The Dalles 62
Boston 60
Lawrence 56
Kraków 55
Marseille 55
Hefei 53
Moscow 53
Frankfurt am Main 52
Nanchang 52
Houston 50
Cattolica 45
Buffalo 44
Redwood City 44
São Paulo 42
Chicago 41
Seattle 38
Bremen 37
Hong Kong 37
Tokyo 33
Kunming 31
Rome 30
Tianjin 29
Shenyang 27
Brussels 25
Dallas 25
Santa Clara 23
Shanghai 23
Mountain View 22
Hebei 21
Helsinki 21
Princeton 21
Brooklyn 20
Norwalk 20
Orem 19
Toronto 19
Changsha 18
Guangzhou 18
Leawood 17
Redmond 17
Boardman 16
Lancaster 16
Warsaw 16
London 15
University Park 15
Fairfield 14
Jinan 14
Mexico City 14
Zhengzhou 14
Fremont 13
Montreal 13
Rio de Janeiro 13
Augusta 12
Belo Horizonte 12
Costa Mesa 12
Hải Dương 12
Paris 12
Stockholm 12
Baghdad 11
Da Nang 11
Jiaxing 11
Nuremberg 11
Chennai 10
Denver 10
Auburn Hills 9
Brasília 9
Hyderabad 9
Kent 9
Roubaix 9
Abidjan 8
Atlanta 8
Düsseldorf 8
Erbil 8
Haiphong 8
Johannesburg 8
Manchester 8
Naples 8
Totale 6.491
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Factors associated with mortality in bacteremic patients with haematologic malignancies 355
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 355
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 354
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 312
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 307
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 306
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 279
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 260
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 238
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 229
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 227
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 222
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 215
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 202
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 197
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 193
Safety and effectiveness of transvenous lead extraction in octogenarians 192
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 187
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 183
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 182
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 181
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 180
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 180
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 177
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 176
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 174
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 170
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 169
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 164
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 160
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 155
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 154
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 154
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 154
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 149
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 149
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 149
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 148
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 148
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 148
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 148
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 147
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 145
Mortality in patients with early- or late-onset candidaemia 144
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 140
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 137
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 136
Mortality in patients, with early-or late-onset candidaemia 135
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 134
Epidemiological and clinical features of pyogenic spondylodiscitis. 133
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 133
Uncommon yeast infections in hematological patients: from diagnosis to treatment 132
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 132
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 131
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 125
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 123
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 116
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 111
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 109
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 109
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 109
Mortality in patients with early- or late-onset candidaemia 108
Isavuconazole-Animal Data and Clinical Data 105
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 104
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 104
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 103
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 102
When Viruses Meet Fungi: Tackling the Enemies in Hematology 102
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 99
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 95
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 94
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 88
Mortality in patients with early- or late-onset candidaemia 85
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 81
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 77
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 75
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 74
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 63
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 62
New advances in management and treatment of cardiac implantable electronic devices infections 61
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 53
Totale 13.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 117 13
2021/2022856 83 83 47 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/20251.371 50 35 109 30 171 51 41 56 213 99 280 236
2025/20263.588 568 97 209 442 759 182 658 197 195 263 18 0
Totale 13.486